According to a market report by Lucintel, the future of the global mesenchymal stem cell therapy market looks promising with opportunities in the orthopedic & musculoskeletal disorder, cardiovascular disease, neurological & CNS disorder, and hematological / immune disorder markets. The global mesenchymal stem cell therapy market is expected to grow with a CAGR of 23.5% from 2025 to 2031. The major drivers for this market are the increasing demand for regenerative treatments, the rising focus on stem cell research, and the growing prevalence of chronic diseases.
A more than 150-page report to understand trends, opportunity and forecast in mesenchymal stem cell therapy market to 2031 by type (autologous and allogenic), source (bone marrow, umbilical cord, adipose, and others), disease indication (orthopedic & musculoskeletal disorders, cardiovascular diseases, neurological & CNS disorders, hematological / immune disorders, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel forecasts that, within the type category, allogenic is expected to witness higher growth over the forecast period.
Within the disease indication category, orthopedic & musculoskeletal disorder is expected to witness the highest growth.
Download sample by clicking on mesenchymal stem cell therapy market
In terms of region, APAC is expected to witness the highest growth over the forecast period.
MEDIPOST, FCB-Pharmicell Co., Ltd., Anterogen, CORESTEMCHEMON Inc., Nipro Corporation, Stempeutics Research Pvt. Ltd., JCR Pharmaceuticals Co., Ltd., Mesoblast Limited, Cell Tech Pharmed, HOLOSTEM S.r.l. are the major suppliers in the mesenchymal stem cell therapy market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at [email protected] to get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: [email protected]
Tel. +1-972-636-5056
Explore Our Latest Publications
Array Instrument Market
Advanced IC Packaging Market
5G mmWave Filter Market
3D Camera Market
Advanced Authentication Market